tm logo
IMID FOUNDATION
REGISTERED

on 02 Oct 2020

Last Applicant/ Owned by

CELGENE CORPORATION A DELAWARE CORPORATION

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

1853588 filed on 21st Aug 2017

Registration Number

TMA1083216 registered on 02th Oct 2020

Registration expiry Date

02th Oct 2030

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

IMID FOUNDATION

Trademark usage description

pharmaceutical preparations for the treatment of cancer and pharmaceutical preparations for regulating the immune system; pharmaceutical preparations Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer and pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immunological diseases, namely, autoimmune diseases, immunological deficiency syndromes


Classification kind code

11

Class [042]
Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research, namely, development of pharmaceuticals methods for others


Classification kind code

11

Class [044]
Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information that enables users to enter, access, track and generate health care information and reports via an interactive website; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries


Classification kind code

11

Mark Details


Serial Number

1853588

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 15th May 2020
Approved
Submitted for opposition 48
on 08th Jan 2020
Agent Changed
Submitted for opposition 15
on 08th Jan 2020
Correspondence Created
Submitted for opposition 15
on 12th Aug 2019
Correspondence Created
Submitted for opposition 15
on 18th Mar 2019
Correspondence Created
Submitted for opposition 22
on 25th Sep 2018
Search Recorded
Submitted for opposition 20
on 25th Sep 2018
Examiner's First Report
Submitted for opposition 31
on 24th Aug 2017
Formalized
Submitted for opposition 1
on 22nd Aug 2017
Created
Submitted for opposition 30
on 21st Aug 2017
Filed